ORGANIZED
International Society of Nutritional Oncology
LANGUAGE
International Society of Nutritional Oncology (ISNO)
We inform you of the First Scientific Meeting of the International Society of Nutritional Oncology that will be in Valencia (Spain), the 1st and 2nd of June 2018.
Besides 2 days of practical lectures in the field of oncology with the newest scientific information supporting the use of nutrition and nutritional products in the treatment and prevention of cancer, there will be attention to the organizational structure and function of the society.
The language of the First Scientific Meeting will be in English, and there will be simultaneous translation English/Spanish and Spanish/English.
For the Society, we propose to have a website which includes a part where only the members can contact private information, for example complete scientific articles related to the use of nutritional oncology.
ISNO can develop international protocols for the support of high quality nutrition in oncology in order to support the best treatment possible for oncology patients, allowing knowing positive and negative interactions with conventional medication (chemotherapy, radiotherapy, hormonal therapy, monoclonal antibody therapy, etc.).
The review article of Velicer CM and Ulrich CM: Vitamin and Mineral Supplement use among US Adults after Cancer diagnosis, J Clin Oncol 2008; 26:665-673 clearly supports the need for a society such as ISNO. In their introduction the authors state that the question of whether supplements can reduce treatment adverse effects, decrease chances of recurrence, and improve survival is of great interest to cancer patients. They analyzed the supplement (vitamins/minerals) use of 32 studies between 1999-2006. 64 to 81% of survivors reported use of these supplements.
However up to 68% of the physicians are unaware of this supplement use. Reasons may be the patient does not inform their physicians, the physicians does not ask for it or does not record this on the medical chart.
Studies addressing the effect of nutrition or supplements on cancer are considered not enough consistent.
However the NGOO (Nederlands Genootschap Orthomoleculaire Oncologie) has compiled more than 3000 articles from randomized controlled studies demonstrating the effects of natural substances (mainly nutritional) in the treatment of cancer.
Nutrient supplementation is intended to improve the survival and quality of life of patients with solid and non-solid tumors.
Nutritional supplementation may improve the survival of cancer patients. Vitamin supplementation can help reduce mortality and risk of recurrence in women undergoing breast cancer treatment.
Today we know that nutrition may be important at the level of chemoprevention and as an therapeutic adjuvant.
Chemoprevention is the use of natural products, including food, medication, supplements, diet to intervene in the early stages of cancer and prevent its expansion.
Chemo-preventive agents can stop genetic mutations and destroy cancer cells.
Chemoprevention is used to increase the health of humans and to decrease the risk of cancer.
Chemoprevention works in healthy persons to prevent the disease.
Regarding the diet and nutrients as additional treatment, there are many publications. The additional treatment may support, improve, potentiate conventional therapies (chemotherapy, radiotherapy, surgery, hormone therapy, etc.) and may decrease the side effects of them.
The major factor in the morbidity and mortality of cancer patients is metastasis. A healthy diet and lifestyle can not only inhibit tumorigenesis but can also have a major impact on metastasis by stimulating metastasis suppressor genes. Diet, Vitamin D, ginseng, lycopene, curcumin, pomegranate, fish oil etc. work against cancer metastasis epigenetically by expressing genes that suppress metastasis. (Gary G. Meadows; Cancer Metastasis Rev; 2012; 31: 441-454). This relatively new approach has a relative lack of knowledge and is a fruitful area of investigation.
Micronutrients such as vitamins, minerals, trace elements, coenzyme Q 10, etc. may help cancer patients by giving them more energy, improve their health status, enhance the activity of conventional therapy and decrease resistance to chemotherapy.
But what micronutrients? What negative interactions can exist and therefore should not be used in certain types of cancers and treatments? What positive interactions can we expect with certain micronutrients? How to manage them? and when? These are all continuing issues among doctors who treat cancer patients.
We must value, study, protocol and interact with all of us to achieve a real optimal most effective integrative oncology.
Atentamente
Dr Antonio Marco Chover
drmarcochover@drmarcochover.com
E Vogelaar
